1 IDEA-FAST Goals

identifying novel digital measures for fatigue and sleep disturbances that will provide more objective, sensitive and reliable measures of the severity and impact of these symptoms in the person’s normal surrounding.

2 Clinical Validation Study

one year longitudinal study with approximately 2000 subjects will be conducted

3 Participant Recruitment

Participants with neurological or immunological disorders from various countries will be screened and recruited

4 Participant visits at the recruitment center

Participants with neurological or immunological disorders from various countries will be screened and recruited

5 Wearing devices at home

All participants will be given a combination of 2-4 digital devices for use in their own environment for several periods

6 Data Collection

Data on fatigue, sleep, selected activities of daily living and other relevant contextual information will be collected by smartphone several times a day while using the devices

7 Data Analysis

In order to establish which devices are suitable for use, complex data analysis will be performed

8 Validation of devices

The devices that met the criteria will be considered for future use in clinical trials

9 Share & Use

The novel clinically validated digital endpoint will be able to:

  • offer deeper insight into disease impact
  • lead to faster clinical development of new therapies
  • provide a more valid and complete assessment of the impact of diseases and treatments

Latest News

2nd General Assembly

The 2nd General Assembly was held as a virtual meeting on 8th – 9th March 2021, with around 130 participants from all partners as well as external members of the Scientific Advisory Board and the Patient Specialist Advisory

Read More »

Events

There are no upcoming events.